Table 1.
Literature summary on discrete choice experiments applied to PreP
Study | Country | Target population | n | Mode of administration | Attributes and levels |
Minnis et al24 | South Africa | sexually active, PrEP-naive youth | 807 | Face to face | Five attributes: form, dosing frequency, access, pain, and insertion site. Across all groups, duration of effectiveness was the most important attribute, with strong preference for less frequent dosing. |
Dubov et al25 | USA | MSM | 554 | Not explicit | Five attributes related to PrEP administration: dosing frequency, dispensing venue, prescription practices, adherence support and costs. |
Kuteesa et al26 | Uganda | HIV-negative members of fshing communities | 713 | Face to face | Product attributes were: HIV prevention effectiveness, sexually transmitted infection (STI) prevention, contraception, waiting time and secrecy of use. |
Lancaster et al27 | Malawi | Female sex workers | 150 | Face to face | Final attributes included: dispensing location (STI clinic, family planning clinic, ART clinic, NGO-run drop-in centre, NGO-run mobile outreach), clinic wait time (1 hour, 2 hours, 3 hours), provider gender (male or female), frequency of pick-up (1 month, 2 months or 3 months) and provision of additional services (risk counselling, cervical cancer screening, pregnancy testing or contraceptives). Dispensing location was most preferred, followed by the provision of additional services. Women preferred receiving PrEP at family planning clinics or NGO run drop-in centres. |
Dubov et al28 | Ukraine | MSM | 1184 | Online | Five attributes related to PrEP administration: dosing frequency, dispensing venue, prescription practices, adherence support and costs. |
ART, antiretroviral therapy; MSM, men who have sex with men; NGO, non-governmental organisation; PrEP, pre-exposure prophylaxis.